Corentec Co Ltd
Corentec Co Ltd operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to the market.
Business. Corentec Co Ltd (104540.KQ) is a South Korean company operating in the Medical Equipment, Supplies & Distribution industry within the broader Healthcare Services & Equipment sector. The firm primarily engages in the sale of medical products and equipment. It is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Corentec Co Ltd (104540.KQ) is a South Korean company operating in the Medical Equipment, Supplies & Distribution industry within the broader Healthcare Services & Equipment sector. The firm primarily engages in the sale of medical products and equipment. It is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue breakdowns are not available.
Corentec Co Ltd has a liquidity position that is currently medium, with a current ratio of 1.24 and a debt-to-equity ratio of 0.66. The company's price-to-book ratio is 0.85, indicating that the market value is trading below the book value. However, the company's negative net cash position after subtracting total debt raises concerns about its short-term liquidity.
Profitability metrics for Corentec are weak, with a return on equity of -0.0041 and a return on assets of -0.0017. These figures suggest that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is minimal at 22,452,620 KRW, and the net income is negative at -304,057,190 KRW, indicating a loss-making position.
The company's revenue concentration is not disclosed in the available data, but the lack of segment or geographic breakdown suggests that it may be operating in a single market or with a limited product portfolio. This could pose a risk if the company is overly dependent on a single revenue stream or geographic region.
Looking at the growth trajectory, Corentec has not provided specific numeric deltas for the current or next fiscal year. However, the negative operating and free cash flows suggest that the company is not in a growth phase and may be facing operational challenges. The capital expenditure of -2,977,072,270 KRW indicates that the company is not investing in new projects or expanding its operations.
The risk assessment for Corentec highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position is a key flag, indicating potential difficulties in meeting short-term obligations. The dilution risk is low, suggesting that the company is not likely to issue additional shares in the near term.
Recent events and filings for Corentec are not detailed in the available data. The company's financial performance, as reflected in its latest financial snapshot, shows a loss-making position with negative net income and operating cash flow. These factors may have influenced recent business decisions or strategic adjustments.
- Corentec Co Ltd is currently experiencing a loss-making position with a negative net income and operating income.
- The company's liquidity position is medium, with a current ratio of 1.24 and a debt-to-equity ratio of 0.66.
- Profitability metrics are weak, with a return on equity of -0.0041 and a return on assets of -0.0017.
- The company is not investing in new projects or expanding its operations, as indicated by the negative capital expenditure.
- The risk assessment highlights a medium liquidity risk and a low dilution risk.
Bull / Bear case
Generated · model-assistedNet income surged 342.2% year-over-year to 6.26 billion KRW, demonstrating strong recent profitability recovery.
Free cash flow turned positive to 6.46 billion KRW, a 325.9% increase from the prior year's deficit.
Revenue grew 17.3% year-over-year to 100.43 billion KRW, indicating robust top-line expansion momentum.
Cash conversion ratio of 31.37% ranks as best-in-class compared to the 0.84% cohort median.
Long-term debt decreased to 31.65 billion KRW, reducing leverage from 53.22 billion KRW in the prior period.
The company faces high credit risk, posing potential challenges for financial stability and borrowing costs.
Debt-to-equity ratio of 0.66 is in the bottom quartile, exceeding the cohort median of 0.20.
Medium liquidity risk suggests potential difficulties in meeting short-term financial obligations or operational needs.
In focus — financials by report
Revenue KRW 63.91B, +43,2% YoY; Operating income +168,8% YoY.
- ▍Revenue KRW 63.91B, +43,2% YoY
- ▍Operating income +168,8% YoY
- ▍Net income +133,1% YoY
- ▍Free cash flow +95,7% YoY
- ▍Net margin 2.8%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Corentec Co Ltd Market data — financials · 2026-05-26